Ind-Swift Laboratories Limited
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
Key metrics
Price as of 2026-07-17
Stock price
₹231.47
Market cap
2,010 Cr
Stock P/E
47.7
P/B
1.45
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 310 Cr | 600 Cr | 888 Cr | 1,281 Cr | 33 Cr | 45 Cr | 9 Cr | 138 Cr | 153 Cr | 153 Cr | 151 Cr | 170 Cr |
| Operating expenses (approx.) | 244 Cr | 461 Cr | 699 Cr | 595 Cr | 32 Cr | 43 Cr | 9 Cr | -73 Cr | 135 Cr | 133 Cr | 125 Cr | 152 Cr |
| EBITDA | 66 Cr | 139 Cr | 189 Cr | 686 Cr | 1 Cr | 3 Cr | -0.72 Cr | 211 Cr | 18 Cr | 19 Cr | 26 Cr | 18 Cr |
| OPM % | 21.2% | 23.2% | 21.3% | 53.6% | 4.2% | 5.8% | -8.3% | 152.7% | 11.9% | 12.7% | 17.2% | 10.4% |
| Other income | 6 Cr | 13 Cr | 20 Cr | 45 Cr | 11 Cr | 24 Cr | 14 Cr | 4 Cr | 15 Cr | 18 Cr | 28 Cr | 2 Cr |
| Interest | 20 Cr | 42 Cr | 63 Cr | 51 Cr | 0.17 Cr | 0.58 Cr | 0.11 Cr | -27 Cr | 1 Cr | 2 Cr | 0.67 Cr | -2 Cr |
| Depreciation | 14 Cr | 27 Cr | 41 Cr | 53 Cr | 0.25 Cr | 0.47 Cr | 0.25 Cr | 7 Cr | 7 Cr | 7 Cr | 9 Cr | 8 Cr |
| Profit before tax | 32 Cr | 70 Cr | 86 Cr | 582 Cr | 0.98 Cr | 2 Cr | -1 Cr | 230 Cr | 10 Cr | 10 Cr | 16 Cr | 12 Cr |
| Tax % | 17.8% | 17.8% | 19.6% | 26.0% | -2.9% | 10.0% | 99.5% | 3.6% | 16.5% | 22.2% | 24.4% | -26.3% |
| Net profit | 17 Cr | 49 Cr | 68 Cr | 421 Cr | 0.94 Cr | 1 Cr | 0.0062 Cr | 222 Cr | 9 Cr | 8 Cr | 10 Cr | 15 Cr |
| EPS (₹) | ₹2.92 | ₹8.28 | ₹3.29 | ₹71.24 | ₹0.16 | ₹0.23 | ₹0.00 | ₹32.96 | ₹1.28 | ₹1.00 | ₹1.17 | ₹1.81 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021 | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 757 Cr | 780 Cr | 891 Cr | 1,039 Cr | 1,207 Cr | 1,281 Cr | 562 Cr | 641 Cr | Sign in for TTM |
| Operating expenses (approx.) | 510 Cr | 602 Cr | 709 Cr | 800 Cr | 1,005 Cr | 640 Cr | 277 Cr | 560 Cr | Sign in for TTM |
| EBITDA | 247 Cr | 178 Cr | 183 Cr | 239 Cr | 203 Cr | 641 Cr | 285 Cr | 81 Cr | Sign in for TTM |
| OPM % | 32.6% | 22.8% | 20.5% | 23.0% | 16.8% | 50.0% | 50.8% | 12.6% | Sign in for TTM |
| Other income | 27 Cr | 33 Cr | 23 Cr | 43 Cr | 34 Cr | 45 Cr | 81 Cr | 47 Cr | Sign in for TTM |
| Interest | 83 Cr | 107 Cr | 100 Cr | 96 Cr | 92 Cr | 51 Cr | 3 Cr | 1 Cr | Sign in for TTM |
| Depreciation | 104 Cr | 90 Cr | 87 Cr | 131 Cr | 57 Cr | 53 Cr | 24 Cr | 31 Cr | Sign in for TTM |
| Profit before tax | 59 Cr | -20 Cr | 18 Cr | 13 Cr | 87 Cr | 582 Cr | 258 Cr | 49 Cr | Sign in for TTM |
| Tax % | 35.0% | -7.2% | 117.5% | 117.1% | 44.7% | 26.0% | 2.8% | 15.8% | Sign in for TTM |
| Net profit | 38 Cr | -21 Cr | -3 Cr | -2 Cr | 48 Cr | 421 Cr | 250 Cr | 41 Cr | Sign in for TTM |
| EPS (₹) | ₹10.28 | ₹-4.28 | ₹-0.53 | ₹-0.36 | ₹8.06 | ₹71.24 | ₹37.25 | ₹4.95 | Sign in for TTM |
| Dividend payout % | — | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021 | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 45 Cr | 59 Cr | 60 Cr | 59 Cr | 60 Cr | 59 Cr | 69 Cr | 87 Cr |
| Reserves | 0.0000 Cr | 356 Cr | 333 Cr | 345 Cr | 438 Cr | 872 Cr | 1,173 Cr | 1,384 Cr |
| Borrowings | — | 1,031 Cr | 1,005 Cr | 944 Cr | 862 Cr | 17 Cr | 15 Cr | 6 Cr |
| Other liabilities | — | 185 Cr | 210 Cr | 226 Cr | 281 Cr | 217 Cr | 250 Cr | 284 Cr |
| Total liabilities | — | 1,860 Cr | 1,818 Cr | 1,803 Cr | 1,824 Cr | 1,165 Cr | 1,438 Cr | 1,673 Cr |
| Fixed assets (net) | — | 796 Cr | 735 Cr | 627 Cr | 583 Cr | 5 Cr | 260 Cr | 275 Cr |
| CWIP | — | 4 Cr | 11 Cr | 9 Cr | 8 Cr | — | — | 10 Cr |
| Investments | — | 26 Cr | 36 Cr | 111 Cr | 30 Cr | 111 Cr | 213 Cr | 248 Cr |
| Other assets | — | 845 Cr | 944 Cr | 997 Cr | 1,165 Cr | 661 Cr | 865 Cr | 977 Cr |
| Total assets | — | 1,860 Cr | 1,818 Cr | 1,803 Cr | 1,824 Cr | 1,165 Cr | 1,438 Cr | 1,673 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021 | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 150 Cr | 195 Cr | -181 Cr | -25 Cr | -63 Cr |
| Cash from investing | — | — | — | 5 Cr | -13 Cr | -104 Cr | -110 Cr | -73 Cr |
| Cash from financing | — | — | — | -141 Cr | -186 Cr | 699 Cr | 69 Cr | 142 Cr |
| Net cash flow | — | — | — | 14 Cr | -4 Cr | 414 Cr | -66 Cr | 6 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 132 Cr | 182 Cr | -225 Cr | -90 Cr | -151 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020Standalone only | Mar 2021 | Mar 2022Standalone only | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 314.7% | 21.1% | 5.9% | 26.8% | 9.4% | 62.0% | 21.9% | 3.6% |
| ROE % | 84.9% | -5.1% | 0.0% | -0.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debtor days | — | 187 | 177 | 158 | 152 | 48 | — | — |
| Inventory days | — | 320 | 301 | 287 | 243 | 6 | 185 | 198 |
| Days payable | — | 119 | 111 | 113 | 113 | 57 | — | — |
| Cash conversion cycle | — | 388 | 367 | 331 | 282 | -3 | 185 | 198 |
| Debt / equity | — | 1.60 | 1.67 | 1.49 | 1.26 | 0.02 | 0.01 | 0.0041 |
| Current ratio | — | 2.73 | 3.00 | 3.18 | 3.14 | 2.99 | 3.92 | 3.83 |
| Net debt / EBITDA | 0.00 | 0.00 | 5.43 | 0.00 | 4.16 | -0.65 | -1.45 | -5.23 |
Compare with peers
Loading peers…